Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers

Yizhen Pang, Liang Zhao, Long Sun, Hua Wu and Haojun Chen
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 125;
Yizhen Pang
1Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang Zhao
2The First Affiliated Hospital of Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Long Sun
3Department of Nuclear Medicine of The First Affiliated Hospital of Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Wu
4The First Affiliated Hspital of Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haojun Chen
2The First Affiliated Hospital of Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

125

Background: Accurate clinical staging is crucial to managing gastrointestinal cancer. But 18F-fluorodoxyglucose (FDG) PET/CT has limitations. Targeting fibroblast-activation-protein (FAP) is a newer diagnostic approach for the visualization of tumor stroma, and 68Ga-labeled FAP-inhibitors (68Ga-FAPI) present a promising alternative to 18F-FDG.

Purpose: To evaluate the diagnostic efficacy of 68Ga-FAPI PET/CT in the primary and metastatic lesions of gastrointestinal malignancies, compared with 18F-FDG PET/CT.Materials and Methods: Participants with gastric, duodenal and colorectal cancers, who received contemporaneous 18F-FDG and 68Ga-FAPI PET/CT between October 2019 through June 2020, were retrospectively analyzed. 18F-FDG and 68Ga-FAPI uptakes were compared using the Wilcoxon signed-rank test. McNemar’s test was used to compare the diagnostic performance between the two scans.

Results: 35 participants (median, 64 years; interquartile range (IQR), 53-68 years; 18 men) were evaluated. In treatment-naïve participants (n = 19), 68Ga-FAPI PET/CT upstaged the clinical TNM (tumor-node-metastasis) staging in 4 (21%) participants, compared with 18F-FDG PET/CT. 68Ga-FAPI PET/CT showed a higher tracer uptake in primary lesions (gastric cancer, 12.7 vs. 3.7, P = 0.003; colorectal cancer, 15.9 vs. 7.9, P = 0.03), involved lymph nodes (6.7 vs. 2.4, P < 0.001), bone and visceral metastases (liver-mets: 9.7 vs. 5.2, P < 0.001; peritoneal-mets: 8.4 vs. 3.6, P < 0.001; bone-mets: 4.3 vs. 2.2, P < 0.001; lung-mets: 4.4 vs. 1.9, P = 0.01) than 18F-FDG PET/CT, with higher sensitivities in the detection of primary tumors (100% [19/19] vs. 53% [10/19], P = 0.004), lymph nodes (79% [22/28] vs. 54% [15/28], P < 0.001), bone and visceral metastases (89% [31/35] vs. 57% [20/35], P < 0.001).

Conclusions: 68Ga-FAPI PET/CT was superior to 18F-FDG PET/CT in the detection of primary and metastatic lesions in gastric, duodenal, and colorectal cancers, with higher tracer uptakes of most primary and metastatic lesions.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers
Yizhen Pang, Liang Zhao, Long Sun, Hua Wu, Haojun Chen
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 125;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers
Yizhen Pang, Liang Zhao, Long Sun, Hua Wu, Haojun Chen
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 125;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
  • Using an assumed lung mass underestimates the lung absorbed dose in patients undergoing 90Y radioembolization therapy
  • Safety and efficacy of radioligand therapy with 177lutetium-PSMA-617 within 3 months after 223Radium-dichloride
Show more Oral - PhysicianPharm

Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

  • Multi-Parametric Total-body Dynamic PET/CT imaging in Differential Diagnosis of Benign and Malignant Lymph Nodes
  • 68Ga-Pentixafor PET/CT in the evaluation of post-treatment response for Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma
Show more Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire